Published in Biotech Business Week, August 8th, 2005
Revenues generated by Avid Bioservices, Inc., the company's wholly owned subsidiary, increased $1,645,000 (or 54%) to $4,684,000 compared to $3,039,000 for the prior year. This increase in revenues helped offset the company's consolidated net loss of $15,452,000, or $0.11 per basic and diluted share, compared to a net loss of $14,345,000, or $0.11 per basic and diluted share, for the prior year ended April 30, 2004.
Total revenues for the year increased to $4,959,000 compared to $3,314,000 in fiscal year 2004, an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.